Myosin cross-bridge dynamics in patients with hypertension and concentric left ventricular remodeling

Cameron Donaldson1, Bradley M Palmer, Michael Zile

  • 1Cardiology Unit, University of Vermont, Burlington, VT, USA.

Circulation. Heart Failure
|September 28, 2012
PubMed

Insights

Hypertension (HTN) with concentric remodeling prolongs cross-bridge attachment time in heart muscle, contributing to diastolic dysfunction. Reduced troponin I phosphorylation may be the underlying mechanism.

Area of Science:

  • Cardiology
  • Biophysics
  • Molecular Biology

Background:

  • Hypertension (HTN) leads to concentric left ventricular remodeling and diastolic dysfunction.
  • These conditions are precursors to heart failure with preserved ejection fraction.
  • The myofilament's role in HTN-related diastolic dysfunction remains unclear.

Purpose of the Study:

  • To investigate if myofilament cross-bridge dynamics are altered in patients with HTN and concentric remodeling.
  • To explore the relationship between these alterations and diastolic dysfunction.

Main Methods:

  • Obtained intraoperative myocardial biopsies from HTN patients with concentric remodeling and control subjects.
  • Dissected and demembranated myocardial strips for isometric tension and cross-bridge dynamics analysis.
  • Measured tension-pCa relation and performed sinusoidal length perturbation analysis.

Main Results:

  • No significant difference in the normalized isometric tension-pCa relation between HTN and control groups.
  • Significantly prolonged cross-bridge attachment time at submaximal calcium concentrations in HTN patients.
  • Approximately 25% reduction in troponin I phosphorylation in HTN patients.

Conclusions:

  • Altered cross-bridge dynamics, specifically prolonged attachment time, contribute to slowed relaxation in HTN with concentric remodeling.
  • Reduced troponin I phosphorylation is associated with these functional changes.
  • Decreased phosphorylation of protein kinase A/G sites is a potential mechanism for the observed myofilament dysfunction.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...